Uddin et al. showed that PIM2 played a role in the epithelial–mesenchymal transition of breast cancer, a critical step in promoting cellular motility and ultimately metastases, which they hypothesized to occur through the persistent activation of STAT3, driven by PIM2 activation of IL-1α and IL-8 [32]. Here, PIM2 is linked to breast carcinoma.